KR20230041660A - Hakim For Sheena's Gand Jodha-E - Google Patents

Abstract

A common serological procedure for all pathogens that have protein coding on their outer shell involves entering dead pathogens and their dead genomes to remove pathogens and cancer genes in humans and animals. A device for detecting pathogens in humans, animals, plants, water bodies and air without a blood test observes the spectral signatures emitted from the human body and water and matches them to any pathogens in the device's database, and the electrostatic properties of the pathogens and their genomes. capture them using

Description

Hakim For Sheena's Gand Jodha-E

[0001] Traditional treatment of diseases caused by pathogens has explored treatments by various methods, such as generating serum from animals such as horses or working at the genome level. My invention includes detection and scanning for pathogens by their spectral signatures without the need for blood tests. Each molecule or pathogen has unique spectral characteristics. I approached the problem of treatment by the electrostatic properties of pathogens. All known pathogens are negatively charged. Cancer-causing genes have a positive or negative charge. By applying direct current voltage to the right place with the device I invented, these pathogens and genes can be caught and removed from the body of a person or animal, or from objects and air.

[0002] I also invented an innovative procedure, which I call Local Loop Back. A small sample of 1 mL of the patient's blood is taken and pathogens in the sample are killed. The dead pathogen is then injected or looped back from the same patient's blood into the same patient along with the healthy donor's blood. The advantage of this procedure is that white blood cells meet dead pathogens and remove them, and in this way, white blood cells learn the protein structure of pathogens in the patient's body. Now that the white blood cells know the problem, they are ready to fight off the living pathogen. It may be a vaccine against pathogens. Creating a serum is similar, but a bit more complicated. The present invention also includes overactivating the patient's immune system. So far, there has been no artificial way to overactivate the immune system. This procedure is called remote loopback. A tiny sample of healthy skin tissue from as many donors as the end of the biopsy entered the patient's bloodstream, as well as the donor's healthy blood of the same type as the patient's. The skin tissue is harmless to the patient's body. However, the white blood cells attack the donor's skin cells because they find the foreign cells. This problem is passed on to the immune system. The immune system then has to make more white blood cells to fight the foreign cells. For example, COVID-19 attacks and kills certain types of white blood cells, but this also kills the pathogen. Here, a new and fresh supply of leukocytes is evident. NOTE: General vaccine and serological procedures are for all pathogens that encode proteins in the pathogen's outer shell, the only exception being very few pathogens such as the HIV virus. My Collaboration: Pathogens are difficult to detect because the proteins encoding the viral envelope come from the host white cells, and other types of pathogens other than the HIV virus interfere with the immune system at the DNA level. This vaccine and serological process cannot prevent or treat these very few types of pathogens.

[0003] To date, there is no treatment against pathogens present in body tissues and organs. I know that many patients die from passing pathogens in the bloodstream from infected organs. C Diff colitis or covid-19 is the best example. Ultrasound is virtually harmless to the patient's body, but lethal to pathogens. This is a good way to combat pathogens such as COVID-19 and C-diff colitis, which are known to be present in body tissues and organs in addition to blood. Ultrasound also eliminates pathogens secreted by human cells that create genomes that replicate themselves. Thus, ultrasound kills pathogens and their genomes. The best example of this kind of pathogen is COVID-19, an infection in the lungs and digestive system, etc. So this method is included in my patent application. The only thing is, you may need some anesthesia, and ultrasound causes severe pain.

[0004] My goal in this patent application is to detect pathogens in humans, animals, plants, water bodies and air without blood testing or collection. I also created innovative procedures aimed at eliminating human and animal pathogens and cancer genes. Pathogens in the air, open spaces, plants and water bodies can also be eliminated. I also aimed to overactivate the body's immune system.

[0005] The present invention includes detection and scanning for pathogens by their spectral signatures without the need for blood tests. Each molecule or pathogen has unique spectral characteristics. I approached the problem of treatment by the electrostatic properties of pathogens. All known pathogens are negatively charged. Cancer genes have a positive or negative charge. By applying direct current voltage to the right place with the device I invented, these pathogens and cancer genes can be caught and removed from the body of a person or animal, or from objects and air.

[0006] Also developed a procedure called Local Loop Back. The local loopback procedure applies to humans and animals. A small sample of the patient's blood is taken and the pathogens in the sample are killed. The dead pathogen is then injected or looped back from the same patient's blood into the same patient along with the healthy donor's blood. The advantage of this procedure is that white blood cells meet dead pathogens and remove them, and in this way, white blood cells learn the protein structure of pathogens in the patient's body. Now that the white blood cells know the problem, they are ready to fight off the living pathogen. It can be a vaccine against pathogens. Serum is made in the same way, but a bit more complicated. The present invention also includes overactivating the patient's immune system. I call this procedure remote loopback, and vans are used for humans and animals. A very small sample of healthy skin tissue from as many donors as the end of the biopsy entered the patient's blood, along with fresh, clean blood from a donor of the same type as the patient's. The skin tissue is harmless to the patient's body. However, the white blood cells attack the donor's skin cells because they find the foreign cells. This problem is passed on to the immune system. The immune system then has to make more white blood cells to fight the foreign cells. For example, COVID-19 attacks and kills certain types of white blood cells, but this also kills the pathogen. Here, a new and fresh supply of leukocytes is evident.

[0007] Ultrasound is virtually harmless to a patient's body, but fatal to pathogens. Ultrasound is used to remove pathogens from organs and tissues of animals and humans. This is a good way to combat pathogens such as COVID-19 and C-diff colitis, which are known to be present in body tissues and organs in addition to blood. Ultrasound also eliminates pathogens secreted by human cells that create genomes that replicate themselves. Thus, ultrasound also kills the pathogen's genome. The best example of this kind of pathogen is COVID-19, an infection in the lungs and digestive system, etc. So this method is included in my patent application. However, since ultrasound causes severe pain, anesthesia may be required. It is enough for plants to receive ultrasound.

Figure 1: The HPC device (1H) detects human or animal pathogens.
Figure 2: HPC device 1A detects airborne pathogens.
Figure 3: HPC device (1W) detects pathogens in water.
Figure 4: HPC device 2 cleans blood from pathogens.
Figure 5: HPC device (3)
Figure 6: HPC device 4

[0008] My goal in this patent application is to detect diseases that cause airborne pathogens in the human body, animals, water bodies, and living spaces without blood testing or collection. I also created innovative procedures aimed at eliminating disease-causing pathogens and cancer genes in humans and animals. Airborne pathogens in living spaces, plants and water bodies can also be eliminated. I also aimed to overactivate the body's immune system.

[0009] The present invention includes detection and scanning for disease pathogens by their spectral signatures without the need for blood tests. The pathogens of any disease have unique spectral characteristics. Spectral signatures of all known pathogens will be stored in what I call HPC Device 1H. After scanning the patient, the processor in the HPC device 1H will determine whether the observed spectral signature matches any pathogen in the database. In case of a match, the instrument HPC 1H will warn the patient that he has that particular pathogen in his body. See Figure 1 for this device. The device has an infrared sensor for focusing on organs. The operator will look at the monitor to see if the representation of the organ is within the screen limits. If the patient's organ is not within limits, the operator will adjust the scanner's position or the patient's position until the organ is in focus of the monitor. After focusing, the HPC device 1H can emit ultraviolet waves or X-rays onto the focused organ. It is better to use UV light. A 100 watt ultraviolet emitter or a 50 watt X-ray emitter will provide clear spectral images without harming the patient's body. These two settings for emitter power mentioned above can be detrimental to the patient. Under these two settings for emitter power mentioned above, blurry or low quality spectral images can be produced. I prefer UV rays because they are less harmful than X-rays. At 5 seconds of UV emission, 1000 scans were taken. The spectral signature emitted from the body was observed by HPC Device 1H and matched to any pathogen in HPC Device 1H's database. Organs selected for COVID-19 include lungs, respiratory pathways, lower GI, and nerve pathways. Your doctor will decide which organs should be scanned for pathogens. Scans of the entire arm are also performed by hand from the shoulder to the border to detect pathogens in the patient's bloodstream. These same scanner-detectors are used to detect pathogens in animals.

[0010] There are two other variants of this scanner-detector device of [0009]. HPC unit 1W is used for water, and HPC unit 1A is used for air. See Figures 2 and 3. For these two devices, no infrared scanner or focusing is required. The HPC device 1A can emit ultraviolet waves or X-rays for spectral analysis. The emitter power is indicated in the following sentence. However, while other power settings are possible, the following power settings are recommended for emitters in order to achieve better spectral clarity and at the same time not to damage the environment. It is better to use UV light because it is less harmful. A 10KW ultraviolet emitter is selected. 1000 scans were made in 5 seconds. The spectral signature emitted from the air observed by this device, HPC Device 1A, matches any pathogen in HPC Device 1A's database. HPC device 1A scans up to 2 miles in any direction. If X-ray is selected for the HPC device 1A, the power of the emitter is 5 KW and can detect up to 2 miles in radius. HPC unit 1W is used for water. If the X-ray is selected for the HPC device 1W, the power of the emitter is 50KW and can detect a maximum radius of 2 miles. The emitter can enter water about 1 meter below the air surface and scan up to 2 miles in any direction underwater in a hemisphere area. For better quality of the spectral image, 1 meter is the maximum depth at which the emitter is immersed in water. The HPC device (1W) could irradiate ultraviolet waves or X-rays for spectroscopic analysis of water. It is better to use UV light. A 100KW ultraviolet emitter is selected. 1000 scans were made in 5 seconds. The spectral signature emitted from the water was observed by HPC Device 1W and matched to any pathogen in HPC Device 1W's database.

[0011] Due to the negative charge in the pathogens, they are captured by a pair of plates attached to a DC power supply, the negative pole repeller and the positive plate trap the pathogens. After detection by the HPC device 1W of [0010], to clean the water of the pathogen, I chose a pair of square cupper plates. This plate can be made in lm and is 1 inch thick. One plate is attached to the positive side of the 100 KW power supply and the other plate is attached to the negative side of the same power supply. There is a distance of lm between the two plates. NOTE: Most pathogens congregate near the water surface. These two plates are submerged in a body of water. These two plates can be loaded into a small boat. After a two-hour boat ride, the plates are heated in an oven at 1000 degrees Fahrenheit for 20-30 minutes to kill waterborne pathogens. This process continues until most of the pathogens are eliminated.

[0012] In order to purify the air of pathogens, after detection by the HPC device 1W of [0010], I chose a pair of square cupper plates. This plate can be made in lm and is 1 inch thick. One plate is attached to the positive side of the 10 KW power supply and the other plate is attached to the negative side of the same power supply. There is a distance of lm between the two plates. These two plates can be loaded into a small car like a pickup truck. After traveling in the car for 2 hours, the plates are heated in a 1000°F oven for 20-30 minutes to kill airborne pathogens. This process continues until most of the pathogens are eliminated.

[0013] I have approached the treatment of disease-causing pathogens by their electrostatic properties. All known pathogens are negatively charged. Cancer-causing genes have a positive or negative charge. Amoebas also come in two types: positively charged and negatively charged. By applying a DC voltage at the appropriate plate of the device discussed in this paragraph, we can catch and take these pathogens and cancer-causing, genes from humans, animals, or airborne pathogens from water bodies and living environments. See Figure 4 - HPC Device 2. Transfer 1 pint of the patient's blood and place it in a jar with the jar at a lower level than the bed surface. After the nurse starts drawing blood, gravity will get the flow into the bottle 10. The ruler 10 has an opening at the top, and blood flows into the ruler 10 through the phlebotomy hose. This continues until the lid of jar 10 comes into full contact with the blood. At that time, the clot removal valve is rotated to stop the flow of blood into the bottle 10 . To compensate for water loss, leukocyte loss, plasma loss: 1000 mg of vitamin C is administered, and concurrently with treatment, if the patient is receiving IV solutions of water and plasma, the remote loop-back procedure mentioned in [0021] can also be used. see Ruler 10 is made of an alloy of copper-aluminum. This jar is processed to have pores of different sizes depending on the disease by the anodic oxidation method, which is widely used for industrial purposes. A special anodizing method is required, which I mention the emphasis in paragraph [0014]. The lids of these jars are generally not anodized unless dealing with amoeba jars. A dielectric material such as flexible plastic is used to ensure that the lid and jar do not have contact. The lid is connected to the negative side of a DC power supply and the jar itself is to the positive side of the same power supply. The power supply has two modes, 25 V or 50 V, either way the total power output is 100 W for best results. In the case of a 25 V setting, it takes about 24 hours to completely deplete the blood from the considered pathogen. For the 50 V setting, it would take 12 hours to do the same job. However, the 25 V setting is healthier for the patient. We are using it to capture the electrostatic properties of pathogens and their genomes. Pathogens and their genomes are negatively charged for all known pathogens. Obviously, pathogens and their genomes will be attracted to the walls of the jar, including the bottom wall, and the lid of the jar 10 will repel them. As will be discussed in paragraph [0014], due to anodization, the pores inside the jar 10 are twice the size of the pathogen considered. For example, if the size of the virtual pathogen is 150 nm, the pores created inside the ruler 10 are selected to be 300 nm. For AIDS and other categories of disease, pathogens infect within some white blood cells. In that case, an additional jar that is anodized to have a pore size twice the size of the contaminated white cells is needed. Obviously, infected white cells will be negatively charged. These infected leukocytes will be attracted to and trapped in the pores of jar 10 for this category of pathogens. For this kind of pathogen, it is strongly recommended to first capture the infected white cells and pour the contents of the jar into another jar with a specific pore size twice the size of the considered pathogen. At this point, infected white cells and considered pathogens are captured in the stomata of the second bottle by electrostatic forces. The contents of the last vial are pathogen-free, infected white blood cells. The contents of this bottle are poured into a blood dispenser and into the patient's artery. Now is the time to kill the pathogen. So far, jar 10, no matter what pore size it has, is still connected to DC electricity, and in this way electrostatic forces will not allow pathogens to escape. After there is no blood in the last bottle, the contaminated bottle may be subjected to 1000°F for about ½ hour to remove pathogens. Clearly, thin plastic insulators must be properly disposed of. Again, in the case of the AIDS category, use a new jar or set of two jars and repeat the above procedure. If the HPC device 1H of [0002] is focused to scan the entire arm from the shoulder to the border with the hand, and the spectral signature of the considered pathogen does not appear on the monitor, the blood is free of the considered pathogen. Taking a small blood sample from the patient is fine, but customary examination under a microscope can be misleading. Taking a blood sample large enough to look at under a microscope would probably be very inconvenient. When the HPC device 1H of [0002] shows no signs of pathogens inside the bottle 10, the electrostatic cleaning of the blood in the bottle 10 continues for 4 more bottles. This is for cases where pathogens can be hiding in strange places. Before sending the patient home, it is advisable to double check by testing with the HPC Device 1H of [0002] with an appropriate blood test. Also, refer to HPC device 3 and HPC device 4 of [0015], namely [0023], for diseases such as corona or C. diff colitis in which pathogens hide inside tissues and organs.

[0014] Anodization is a known industrial process. For the custom design for the present invention, several special considerations were selected for the purpose of capturing pathogens. In this way, this industrial process can have new uses and thus nobility for medical science. The main characteristics of the anodization for the present invention are as follows: I chose an alloy of copper-aluminum/doping. The reason for alloying/doping is to make pores larger than usual when needed. It is a cube-shaped dot-capacity jar made of this alloy. After anodization, the metal pieces of this alloy are first degreased and then electropolished to make the surface smooth before being molded into cubic pots. It also ionizes the alloy to create indentations in copper-aluminum alloy metal pieces, creating larger-sized holes when needed. If not ionized, the maximum possible pore size is 750 nm. For example, when leukocytes are infected with the AIDS virus, larger pores are required to match the size of the infected leukocytes. White cells are larger than 750 nm. In this way, leukocytes infected with the AIDS virus, which are negatively charged due to the presence of the AIDS virus, can be trapped in the pores on the jar when attracted by the electrostatic force and held there until incinerated. In addition, as the time required for the anodizing process increases, the size of pores will increase.

[0015] See FIG. 5 for HPC device 3. The device uses the electrostatic properties of pathogens and their genomes to capture them. If Dr recommends, or device 1 HPCH recognizes pathogens or their genomes inside a tissue or organ, HPC device 3 can extract pathogens or their genomes. The device includes two needles, such as syringe needles. These needles are made of tungsten alloy, available from some specialty suppliers, and are 36 gauge. Both needles are 5 inches long. The tip of one of the two needles has five small grooves. These five grooves have a 45 degree angle to the body of the needle. These five grooves go to the needle's main hollow track. The grooves are created by a professional dealer by means of a fine beam laser. This needle is attached to the positive side of the power supply. The body of this needle is rough, as are the inside of the five grooves and the main track of the needle. The reason for this roughness is that negatively charged pathogens and genomes are attracted to the positive side needle, so we want them to stick and not break. Other needles are simple, have no major tracks or grooves on the inside, and have a smooth surface. This needle is connected to the negative side of the power supply. I chose to set the power supply's voltage setting to either 25 volts or 50 volts. However, voltages between 25 V and 100 V will work. More than 100 V is unhealthy for the patient. Less than 25 V has no effect. The power output of the power supply is 100 W for 50 volts, and the power output is 50 watts for 25 volts. We recommend using the 50 V option. This option is more effective. After cleaning of the blood by the HPC device 2, if the HPC device 4 mentioned in [0023] cannot kill the pathogens inside the organ by ultrasound, after one month, the HPC device 3 removes the pathogens and their genome can be extracted. This procedure involves incising the two aforementioned needles 2 mm from each other. The general location of pathogens and their genomes is determined by the HPC device 1H. The HPC device 3 can capture the considered pathogen and its genome due to the electrostatic attraction between the needle attached to the positive side of the power supply and the negatively charged pathogen and genome. The general location of the incision within 2 mm is also good. In addition, a repulsive force exists between the needle attached to the negative side of the power supply and the pathogen or genome. The repulsive force helps the positive needle to better attract the pathogen or genome. The best thing, if possible, is to make an incision so that the pathogen or genome is now between the two needles looking for trace amounts of the pathogen and genome. However, the device can also be used to take out the genome in one piece. This procedure is relatively non-abrasive and harmless. Usually, after 10 trials, the genome comes out in one piece. NOTE: Treated organs may require anti-edema inflammatory medications. Genomes and pathogens can be grown in the laboratory and then frozen at -60 degrees Fahrenheit for future use.

[0016] The best treatment for pneumonia is this device 3 HPC in my opinion. If, after applying the device 4 HPCs mentioned in [0023], the infection is still present, then, as directed by the HPC device 1H, this incision associated with the device 3 HPC appears to be the best option.

[0017] Based on my experience, the best treatment for cancer is this HPC device 3. Advanced cases of cancer are not curable. The best option is to start this treatment at an early stage of the cancer when the cancer is in a mild stage. Even moderately advanced cancers can be treated with this procedure. Malignant cancers are not treated or tested using this procedure. The power supply used has an output of 50 volts and 100 watts. Other voltages or power sources may not work or cause more damage. The incision is started at the location of the cancer. For example, usually cancerous cells in the liver cause swelling in the liver spots. Those points are the starting points of the incision. The trick is that genes that cause cancer can be either positive or negative. Thus, both needles are of the same type as the positive side needles of this device in [0015]. Both needles have a rough surface inside the main track. Both needles have a rough exterior. The reason for the roughness of the surface has been explained previously. The voltage indicator on the power supply will show voltage spikes and tiny voltage drops. This voltage drop is in microvolts. This is when you know you are holding the cancerous gene. The incision is continued for about 10 hours to free most of the organ from the cancerous gene. Whenever you see a spike in voltage drop, you know you're in the right neighbour. So in this neighborhood, the incision continues until no spikes in the power supply are observed in 5 experiments. Finding cancerous spots X-rays may still be the best option for finding swelling. As mentioned earlier, it is not possible to completely free an organ from cancerous genes, but this is a very good start. Also, needles and organ dissections for 10 hours are still close to being terribly harmless. However, this procedure is much better than conventional surgery. Also, another important advantage of this procedure is that the damage to the needle is so minor that the needle biopsy scar eventually heals with the care of the doctor, good nutrition and rest. This procedure can be repeated on average every 6 months. The above examples are for the liver, but can be used for any soft tissue organ. In the case of brain tumors that have undergone surgery to drain the tumor, this procedure can be performed over three months after surgery. Still we are looking for spikes and voltage drops in power supplies. An incision is made around where the tumor was. This procedure for cancer cannot be done for bone.

[0018] For leukemia, all leukocyte-related organs such as the spleen, thymus, etc. are inspected, that is, inspected by the HPC device 3 and the spike when power is supplied. In the case of Spike, the same device is used to treat the organ. Using the remote loopback procedure mentioned in paragraph [0022], it creates some bony gyrus and leukocytes to compensate and replace the damaged ones. However, it may not be okay for advanced cancer symptoms. In any case, the resulting leukocytes and bone grafts can at least reduce the need for donor bone grafts. The remote loopback procedure described in [0021] is very useful. This can be done on the same day as any cancer treatment. After treating the patient, the needle is sterilized at a temperature of 500 to 1000°F. I chose 550 degrees Fahrenheit. Note: Cancer is known to progress and migrate to other parts of the body even after surgery or other cancer treatment. After the cancer treatments discussed in this section, random checks by HPC Device 3 are recommended for other sites that can be performed. More importantly, there is a ruler similar to ruler 10 of [0014] of HPC device 2 for testing blood, where the gene may be in the blood traveling throughout the body. Again, we are looking at voltage drop spikes on the power supply of HPC Device 2 or HPC Device 3 for scotoma/or genes floating in the blood. For any cancer, especially leukemia, the recommended course of action is to start with Device 2 HPC. We want to capture the genes in the blood and the infected cells with the genes. In this case, the jar is split into two halves, one half connected in the positive direction and the other half connected in the negative direction to a 100 watt, 50 volt power supply. The halves are separated by a dielectric material such as plastic. This can infect blood cells and genes. Clearly, the pores are twice the size of the largest blood cells in question. Plasma transfusion is particularly useful for leukemia. At the same time, the HPC device 3 is used to search the interior of other organs for cancer, where inflammation or swelling may not have started therein.

[0019] Optionally, a micromagnetic coil is wound around each of the two needles for the HPC device 3 while a DC voltage is applied to the coil. This device is somewhat harmful to the patient and is not recommended for coil use as this method is very inefficient.

[0020] Currently, to take out the genome of a pathogen inside an organ, surgeons must use a very abrasive procedure. This abrasive procedure entails something similar to a biopsy, but the surgeon must dig out the tissue with a needle so the genomes can be extracted. Clearly, many cells are plucked with genomes. Sometimes these biopsy-type procedures damage genomes. This procedure is not performed on living patients. Again using the HPC device 3 in paragraph [0015] is superior because whole genomes can be extracted with minimal damage to the patient.

[0021] Also developed a procedure called Local Loop Back. These methods of preparing sera and vaccines are applicable only to pathogens having protein coding incorporated into the envelope. COVID-19 is an example of this category. Local loopbacks operate for sera and vaccinations against COVID-19. This serum or vaccine will not work against AIDS. A small sample of 1 mL of the sick patient's blood is taken and the pathogens in the sample are killed. Care must be taken not to damage the protein coding. The dead pathogen is then injected via an IV or looped back with a pint of healthy blood from a donor of the same type as the patient's blood. This is a vaccine treatment. For serum, four more steps are required. In the first step above, we used a dead pathogen and its dead genome as it multiplies inside the organ's cells. In the next four stages, full dead, ¾ dead, ½ dead and ¼ dead pathogens are required. Completely dead pathogens are inactive. ¼ dead pathogens are close to fully active. ½ dead pathogens are not dangerously active. ¾ Dead pathogens are very inactive. I've been using lab-style microwave ovens to complete dead or dead pathogens. Four additional steps for serum are: Stage 1: 2 days after vaccination, using a mixture of 90% completely killed and 10% ¾ killed pathogens, also in which the pathogens multiply in a pint of blood from a healthy donor into organ cells of the same type as the patient's blood In this case, completely killed pathogens are used together with completely killed pathogens of the above pathogens. Step 2: After 2 days of stage 1, a mixture of 90% complete kill, 5% kill ¾, and 5% anti-kill pathogens is used, wherein the pathogen is inside the organ cells, blood of a healthy donor with the same blood type as the patient proliferate in one pint of Step S: On the second day after step 2, 90% complete killing, 5% ¾ killing, 5% anti-killing, and 20 counts of ¼ killed pathogens, also when the pathogens multiply inside organ cells, complete killing of the pathogens A mixture of genomes is used from a pint of healthy donor blood of the same type as the patient's blood type. Step 4: On the second day after step S, a mixture of 90% complete kill, 5% ¾ kill, 5% half kill, and 20 counts of ¾ kill pathogens is used, in addition, the pathogen is in a pint of blood from a healthy donor, When a pathogen of the same type as the patient's blood type proliferates in organ cells, the pathogen's genome is completely killed. The advantage of this procedure is that the white blood cells encounter and eliminate the dead pathogens and their dead genomes, and in this way the white blood cells learn the protein structures of the pathogens in the patient's body. Now that the white blood cells know the problem, they are ready to fight off the living pathogen. Serum takes 7 months for the pathogens discussed to clear from the patient's blood. 3 months after stage 4 serum treatment, start serum treatment again if you have any symptoms. If the pathogen is present in the tissue of an organ, obviously the disease starts over again. Experience shows that the disease is cured after 4 additional serum applications. Therefore, the use of this serum is as follows. Wait 3 months after using the serum for the first time. If the patient still has any symptoms of the disease, the patient should be cured with 4 additional applications of each of the above serological procedures at one month intervals. For vaccination, pathogens come from diseased donor patients. For better results, please refer to the following paragraph and use the remote loopback calling procedure. Also, fully dead genomes can be added to serum for better results. Also, in paragraph [0022], a procedure called remote loop back was introduced. Very good results can be obtained when this procedure is used with the serum described above. 1000 mg of vitamin C is recommended during serum injection and for several days after injection. Vitamin C is known to promote the development of white blood cells.

[0022] Remote loop back: The present invention involves overactivating the patient's immune system. This procedure is called remote loopback. This method is useful for application concurrently with vaccination or serum application. Vitamin C is known to increase the number of white blood cells, which can be very useful. At the end of the biopsy, a very small sample of skin tissue from a healthy donor entered 1 pint of blood from a healthy donor with the same type of patient blood. This blood is infused into the patient through an IV. The skin tissue is harmless to the patient's body. But since the white blood cells find the foreign substance, they attack the donor's skin cells. This problem is passed on to the immune system. The immune system then has to make more white blood cells to fight the foreign cells. For example, COVID-19 attacks and kills a certain type of white blood cell, but by attacking it, the pathogen is also killed. The need for a new and fresh supply of leukocytes is evident here.

[0023] HPC Device 4: Ultrasound is virtually harmless to the patient's body, but lethal to pathogens. This is a good way to combat pathogens such as COVID-19 and C-diff colitis, which are known to be present in body tissues and organs in addition to blood. Ultrasound also eliminates pathogens secreted by human cells that create genomes that replicate themselves. Thus, ultrasound also kills the genomes of these pathogens. The best example of this kind of pathogen is COVID-19, an infection in the pulmonary system, respiratory tract, digestive system, etc. So this method is included in my patent application. However, since ultrasound causes severe pain, general anesthesia is required. See Figure 6 for the ultrasonic device I invented. I call this HPC Unit 4. The power output of the HPC device 4 is 100 Watts. He says he wants to kill the COVID-19 virus and its genome in a few places in his lungs. Note that the genomes of COVID-19 have a spectral signature different from the spectrum of the entire COVID-19 virus. The HPC device (1H) is used to indicate the point of infection. In this example, all areas of the lung are treated one at a time. In this example, the metal side of the applicator is placed on top of the location of the lungs on the skin surface shown by HPC device 1H. Rub the metal side of the applicator of HPC Device 4 in Figure 5 against the skin area above the problem area. If the nerve pathways are infected by pathogens, this ultrasound device is also used. CAUTION: Spinal general anesthesia should be avoided for any work involving the HPC device 4. Two hours of ultrasound treatment for each organ is sufficient. It is good to wash half of the blood at the beginning of the ultrasound treatment. This purification of blood was performed by the HPC device 2 of [0013]. The trick is that there is a slight chance that the virus from the organs and the patient's blood will travel from the organs to the blood and vice versa. After washing the lungs for COVID-19 and washing the blood of the virus, it is recommended to use the HPC device 1H to confirm the signature of COVID-19 and genome in this example. Any indication of these signatures means repeat blood and organ washing. This continues until all relevant COVID-19 spectral signatures do not appear on the HPC device 1H, and also the last four, represented by the spectral signature on the ruler 10 of HPC device 2 described in [0013] This continues until blood samples show no signs of COVID-19. Remote loopback after ultrasound treatment can be very useful. In addition, anti-inflammatory and anti-swelling medications, especially during use of this procedure, and at the discretion of the Dr, after a few days, by testing for allergies to these types of medications; For treatment of the lungs this can be important.

Claims (132)

Vaccinations that can be used in humans and animals, including entering dead pathogens and their dead genomes, and healthy blood from a donor via IV inside the patient with 1 pint of donor's healthy blood of the same type as the patient's blood contains a tip of biopsy amount of skin tissue; wherein the pathogens and their genomes are killed by heating in a 100 W lab microwave oven between 500-1000°F for at least 20 minutes until the pathogens and their genomes are no longer active; This choice is my favorite, and the best work among the claims made here for vaccines; The pathogen's protein coding must be damaged. The method of claim 1 , wherein said killing of pathogens and their genomes can be achieved by using an oven that creates a fire fueled by any hydrocarbon fuel. The vaccine can be achieved according to claim 1, wherein ultraviolet light is used to kill pathogens and their genomes. A vaccine can be achieved according to claim 1 wherein X-rays are used to kill pathogens and their genomes. The vaccine can be achieved according to claim 1, wherein gamma rays are used to kill pathogens and their genomes. A vaccine can be achieved according to claim 1 wherein infrared light is used to kill pathogens and their genomes. A vaccine can be achieved according to claim 1 wherein any abrasives or harsh chemicals are used to kill pathogens and their genomes. The vaccine can be achieved according to claim 1 , wherein any currently available class of bleaching agent group is used to kill the pathogen and its genome. The vaccine can be achieved according to claim 1 , wherein any pasteurizer with or without a vibrator machine is used to kill the pathogen and its genome. The vaccine can be achieved according to claim 1 , wherein an autoclave set at 500 to 1000° F for at least 20 minutes is used to kill the pathogen and its genome. The vaccine can be achieved according to claim 1 , wherein any enriched antibody material is used for killing the pathogen and its genome. A vaccine can be achieved according to claim 1 wherein any magnetic field device comprising an electromagnetic element with a 100 watt power source is used to kill pathogens and their genomes. The vaccine can be achieved according to claim 1, wherein any one or all combinations of claims 1 to 12 are used for killing pathogens and their genomes. In the general serum procedure for all pathogens that have a protein coding on their outer shell, the only exceptions are very few pathogens; This serum can be used in humans and animals; Serum involves five steps: (a) with 1 pint of healthy blood from a donor of the same type as the patient's blood, via IV, dead pathogens, and their dead genomes, and a biopsy of healthy skin tissue from the donor. entering the tip; wherein the pathogens are treated, i.e. killed, by applying heat at 500-1000°F in a 100 W lab microwave oven until the pathogens and their genomes are no longer active; (b) after 2 days, 90% of the completely killed pathogens and groups of their killed pathogens, and 10% of the ¾ killed pathogens, and the leading edge of the biopsy of the donor's healthy skin tissue, of the same type of donor as the patient's blood. enter the type of pathogen treated of the disease, including with 1 pint of healthy blood; wherein complete killing of pathogens and their killing pathogens is achieved by heating in a 100 W lab microwave oven set at 500-1000 degrees Fahrenheit until the pathogens and their pathogens are no longer active, while the pathogen's protein coding is damaged. ¾ killing of pathogens is achieved by application of heat in a 100 W lab microwave oven, until the pathogen's protein coding is intact, (c) after 2 days, the type of pathogen treated and their genome; 90% of completely killed pathogens and groups of their completely killed pathogens, 5% of ¾ killed pathogens and 5% of ½ killed pathogens, and leading edge of biopsies of donor's healthy skin tissue via IV, the patient's blood and Enter the mixture containing together with 1 pint of healthy blood from a donor of the same type; Here, completely killed pathogens and their deaths are performed individually by applying heat of 500-1000°F in a 100 Watt laboratory microwave oven until the pathogens and their genomes are no longer active, and ¾ killed pathogens are then killed in a microwave oven. This is achieved by applying heat of 500-1000°F in a 100 watt microwave oven, until the pathogen is close to inactive, ½ killed pathogen is achieved by applying heat of 100-1000°F, and the pathogen is not dangerously active. until, (d) after 2 days, 90% of species of killed pathogens and their genomes, and groups of 90% killed pathogens, ¾ 5% of killed pathogens, ½ 5% of killed pathogens and ¼ killed pathogens 20 counts of , and a tip of a biopsy amount of a donor's healthy skin tissue via IV into a mixture containing the same type as the patient's blood; wherein complete killing pathogens and their killing is achieved by heating in a laboratory 100 Watt microwave oven until the pathogens and their genomes are no longer active, and ¾ killing is achieved by heating in a laboratory 100 Watt microwave oven until the pathogens are close to inactive. ½ kill is achieved by heating in a 100 Watt microwave oven, ¼ kill until pathogens are not dangerously active by heating in a 100 Watt microwave lab, ¼ kill is achieved by heating in a 100 Watt microwave lab until it approaches full activity, (e) after 2 days, repeating step (d). 15. The treatment of pathogens and their genomes according to claim 14 wherein an oven that creates a fire fueled by any hydrocarbon fuel is used. 15. The serum according to claim 14, wherein ultraviolet light is used to treat the pathogen and its genome. 15. The serum according to claim 14, wherein X-rays are used to treat the pathogen and its genome. 15. The serum according to claim 14, wherein gamma rays are used to treat the pathogen and its genome. 15. The serum according to claim 14, wherein infrared light is used for the treatment of pathogens and their genomes. 15. The serum according to claim 14, wherein any abrasive or harsh chemicals are used for the treatment of pathogens and their genomes. 15. The serum according to claim 14, wherein any currently available class of bleaching agent group is used for the treatment of the pathogen and its genome. 15. The serum of claim 14 can be achieved wherein any pasteurizer with or without a vibrator machine is used to kill the pathogen and its genome. 15. The serum of claim 14, wherein an autoclave set of 500 to 1000°F is used for treatment of the pathogen and its genome. 15. The serum according to claim 14, wherein any enriched antibody material is used for the treatment of pathogens and their genomes. 15. Serum can be achieved according to claim 14, wherein any magnetic field generator device comprising an electromagnetic element with a 100 watt power supply is used to treat pathogens and their genomes. 15. A serum according to claim 14 wherein any one or all combinations of claims 14 to 25 are used to treat pathogens and their genomes. The HPC device 1H is used for detection of pathogens and genomes in the body; using an infrared sensor focused on the organ for observation; then emits ultraviolet light onto the focused organ; A 100 watt ultraviolet emitter will provide a sharp spectral image that is within the safe zone for the patient; At 5 seconds of ultraviolet emission, 1000 scans were taken to observe and search for the unique spectral signatures of pathogens and their genomes, eg, COVID-19 primary organs, lungs, etc.; A scan of the entire arm from shoulder to edge by hand is also performed to detect pathogens in the patient's bloodstream. 28. The method of claim 27, wherein the device is used to detect a pathogen inside the body of an animal. 28. The device of claim 27, wherein a 50 watt X-ray emitter is used for detection of the pathogen and its genome. 30. The method of claim 29, wherein the device is used to detect a pathogen inside the body of an animal. The HPC device 2 is used to rectify the patient's blood to one pint per hour; By a special anodic oxidation method, the bottle is produced; Each disease pathogen requires a custom-made bottle; DC power supply set to 25 V with a power output of 100 W for best results; Within 24 hours the blood is pathogen free; This is done due to the electrostatic attraction between the disease and the pathogen; Obviously after each use, the jar must be sterilized. 32. The device of claim 31, wherein the DC power supply is set at 50 V and 100 W, and each bottle is a ½ hour process. For pathogens that infect within the body's leukocytes, the device of claim 31 or 32 is used, wherein a further special bottle designed to capture these leukocytes is applied prior to using the bottle of claim 31 or 32. Should be. The HPC device 4 uses ultrasound which is safe for humans and animals and plants, but kills pathogens and their genomes inside the body; The only thing is that general anesthesia is required for animals and humans because ultrasound causes severe pain; The power output of the HPC device 4 is 100 Watts; The HPC device (1H) of claim 27 is used to indicate the infection site; Rub the metal side of the applicator of the HPC device 4 of FIG. 5 against the skin area over the problem area; If the nerve pathways are infected by pathogens, this ultrasound device can also be used; WARNING: Avoid the entire spinal area when using this device; Ultrasonic treatment of 2 hours for each organ is sufficient; If allergy to the drug used is not present, anti-inflammatory and anti-edema may be critically important at the discretion of the Dr; See remote loop-back in item 37. Remote loop-back after ultrasound treatment can be dramatically useful. Pneumonia can be treated with the HPC device (4) using the HPC device (4) of claim 34, i.e. using ultrasound therapy to the lungs. For pathogens that infiltrate body organs, such as C Diff colitis or coronavirus, with or without genomes inside the organ, firstly, the device according to claim 31 is used, wherein the bottle used is specific to that specific must be designed and prepared for pathogens; After washing the blood, the device according to claim 34 is used to wash one organ at a time; After washing the blood using claim 31, start ultrasound treatment according to claim 34; The trick is that there may be some chance that the virus will travel from the organs and from the patient's blood and vice versa; It is recommended to use the HPC device 1H according to claim 27 to check the signature of covid-19 and genomes, eg, in this example, after washing the lungs for covid-19 and washing the blood of the virus; Any display of these signatures means repeating the blood and organ wash again. The present invention includes overactivating a patient's immune system; This procedure is called remote loop back; The method is useful for application concurrently with the vaccination or serum application of claims 1, 14; A very small sample of healthy donor skin tissue, such as a tip of a biopsy, entered into 1 pint of blood from a healthy donor having the same type of blood as the patient's blood in the patient's blood via IV; The skin tissue is practically harmless to the patient's body, but since the white blood cells detect foreign cells, they attack the donor skin cells, and these substances are passed on to the immune system; The immune system must then produce more white blood cells to fight off the foreign cells; Vitamin C is known to increase the number of white blood cells, which is a great help. Device HPC 1A is used for the detection of airborne pathogens (see Figure 2); The apparatus is similar to claim 27, wherein the infrared scanner is omitted and only a 10KW ultraviolet emitter is selected; Taking 5 secondary emissions, 1000 scans, the spectral signature emitted from air was observed by HPC Device 1A to match any pathogen in Device HPC 1A's database; HPC unit 1A scans up to 2 miles in any direction. 39. The method of claim 38, wherein X-rays are selected instead of ultraviolet, and when X-rays are selected for the device HPC 1A, the power of the emitter is 5KW and the device capable of detecting up to a radius of 2 miles is used. In order to clean the air of pathogens, after detection by device HPC 1A in item 38, 1 selected a pair of square cupper plates, which plates may be lm by lm, and are 1 inch thick; One plate is attached to the positive side of the 10 KW DC power supply, and the other plate is attached to the negative side of the same power supply; There is a distance of lm between the two plates, and these two plates can be loaded into a small pickup truck; After 2 hours of travel by the car, the plates are heated in a 1000°F oven for 20-30 minutes to kill pathogens trapped from the air. 41. The method of claim 40 wherein a magnetic field generator having a strength of 100 megahenries with 100 windings and a 10K ampere DC voltage may alternatively be used; Instead of supplying DC power to the plate, DC power is attached to the windings; The polarity of the DC supply in the windings attracts negatively charged pathogens. The device HPC 1W is used to detect pathogens in water; The emitter can go into water about 1 meter below the air surface and scan up to 2 miles in any direction underwater over a hemisphere area; For better quality of the spectral image, 1 meter is the maximum depth the emitter can go underwater; 100KW ultraviolet emitter is selected; For 5 seconds, 1000 scans are taken; The spectral signature emitted from the water is observed by HPC Device 1W to match for any pathogen in HPC Device 1W's database. 43. The device of claim 42, wherein X-rays are used instead of ultraviolet light, the power of the emitter is 50 KW and it can detect up to a radius of 2 miles. After detection by the HPC device (1W) in claims 41 or 42 to clean the body of pathogens, this plate can be lm by lm and is 1 inch thick; One plate is attached to the positive side of a 100 KW DC power supply, while the other plate is attached to the negative side of the same power supply, with a distance of lm between the two plates; Note: Most pathogens congregate on the very near surface of the water surface, these two plates are submerged in the water body, and these two plates can be loaded into a small boat; After 2 hours of travel by boat, the plates are heated in an oven at 1000 degrees Fahrenheit for 20-30 minutes to kill waterborne pathogens; The process continues until most of the pathogens are eliminated. 45. The method of claim 44 wherein a magnetic field generator having a strength of 10 megahenries with 100 windings and an IK amp DC voltage may alternatively be used; Instead of supplying DC power to the plate, DC power is attached to the windings; It is clear that the polarity of the DC supply in the windings is what attracts the negatively charged pathogens. In the case of the Fig. 5HPC device (3), this device uses the electrostatic properties of pathogens and their genomes to capture them, recommended by Dr. or the HPC device (1H) of item 27 inside tissues or organs. , the device (3) HPC is capable of extracting the pathogen or its genome, the device includes two needles, such as syringe needles, which are 36 gauge and 5 inches long; There are 5 small grooves on the tip of one of the needles, these 5 grooves have a 45 degree angle to the body of the needle and lead the main hollow track of the syringe like a syringe needle; This needle is attached to the positive part of the power supply which may have a DC voltage of 25-100 volts; The body of this needle is rough, so there are 5 grooves and the inside of the main track of the needle; The reason for this roughness is that negatively charged pathogens and genomes are attracted and attached to the positive side needle, so they want to stay attached and remain free; The other needle is simple, has no major tracks or grooves, has a smooth surface, and is connected to the negative part of the power supply; The best operating mode is 50 volts and the power output is 100 watts for 50 volts, this option is more effective; After cleaning the blood by the device (2) HPC of claim 31, if the HPC device (4) of claim 34 cannot kill the pathogens inside the organ by ultrasound, the device (3) HPC can take out pathogens and their genomes. there is; This procedure involves incising the aforementioned two needles 2 mm from each other, and the general location of pathogens and their genomes is determined by the HPC device (1H) of claim 27; Also, the positive side needle attracts, while the negative side needle mostly repels the positive side needle due to the electrostatic force; Usually after 10 trials, even the genome comes out in one piece. Genomes and pathogens can be grown in the laboratory and then frozen at -60 degrees Fahrenheit for later use. If the device of claim 46 is used for pneumonia and the device of claim 34 does not effectively clear the infection; Use all precautions listed in Section 34. Since both needles are of the same type as those used for the positive side of claim 46, and the amoeba can be positive or negative, they can be used in the case of the blood contamination device of claim 31, and the trick is that the negatively charged amoeba can be used on the positive side, i.e. Amoeba attracted to the container body of claim 31, positively charged amoeba is caught by the container lid, and it is clear that the negative and positive poles of the power supply are interchangeable by Dr's decision depending on the circumstances. Use of claim 46 for disease. The best treatments for cancer genes are the HPC device 3 of claim 46 and the HPC device 2 of claim 31 . Progressive cases of cancer are generally not curable, but it may be useful to try. Even mid-stage advanced cancers can be cured by this procedure; The power source used has an output of 50 volts and 100 watts, any other voltage or power will have no effect or cause more damage; Start the incision at the site of the appearance of the cancer, for example, in the liver, usually cancer cells cause swelling, and the points become the starting point of the incision; The trick is that cancer-causing genes can be either positive or negative, so both needles are the same kind as the needle on the positive side of the device; One can look at the voltage indicator on the power supply so you can get minuscule voltages, which can get minuscule voltages in microvolts, but this is what you see when you catch cancer genes; The dissection goes on for about 10 hours, freeing most of the organ from the cancerous gene, and the minuscule drop in voltage lets you know you're in the right neighborhood, so you can get a minuscule spike in the power supply for 5 tests at that point. Continue dissection until not observed for ; X-rays are still the best option to find swelling, and while completely freeing organs from cancerous genes is not possible, this is a very good start; A 10-hour incision with a needle into an organ is still relatively harmless, but the procedure is far superior to conventional surgery; This procedure may be repeated every 6 months but is used for all soft tissue organs; Note: Cancer is known to progress and migrate to different parts of the body even after surgery or any other cancer treatment; After cancer treatment, recommend random examination by HPC device (3) for different parts of the body to be done; Again we are watching the voltage drop spike on the power supply of the HPC device (3) for the cancer gene spots. More importantly, it is an HPC device 2 for testing blood, where the gene may be in the blood traveling throughout the body. Again, the present inventors observe voltage drop spikes in the power supply of the HPC device (3), or the HPC device (2) of claims 31 and 42 for cancer gene spots/or genes floating in the blood. For any cancer, especially leukemia, the recommended course of action is to start with Device 2 HPC; We want to grab the gene from the blood and catch the infected cells that have the gene. In this case, the jar is split into two halves, one half connected in the positive direction and the other half connected in the negative direction to a 100 watt, 50 volt power supply. The halves are separated by a dielectric material such as plastic. This can infect blood cells and genes. Clearly, the pores are twice the size of the largest blood cells in question. At the same time Device 3 HPC is used to search inside cancer, damaged organs, rather strongly recommended for detecting genes in blood, blood or plasma; The above procedure of this paragraph is also used for brain tumors, say 3 months after surgery when the tumor has been removed; Still we are looking for spikes and voltage drops in the power supply, and the incision is made around where the tumor is located. For leukemia, all soft tissue leukocyte related organs such as spleen, thymus, etc. must be treated; After treatment, use the remote loop-back procedure described in claim 37, which produces some bone heterogeneity and leukocytes to compensate and replace the damaged ones; The resulting bone heterogeneity uses the procedure described in item 49, which can at least reduce the need for donor bone heterogeneity. 32. The method of claim 31, wherein a magnetic field generator having a strength of 2 kilo Henries may alternatively be used; Obviously, the polarity in the windings is to attract negatively charged pathogens. 33. The method of claim 32 wherein a magnetic field generator having a strength of 2 kilo Henries may alternatively be used; Obviously, the polarity in the windings is to attract negatively charged pathogens. 47. The method of claim 46 wherein a magnetic field generator with a strength of 2 kilohenries may alternatively be used; there is a winding to be wound around the needles; Instead of a DC power source attached to the needles, a DC power source is attached to the windings; Obviously longer needles are required; Obviously, the polarity of the DC power supply in the windings causes the negatively charged pathogen to be attracted to the device. 50. The method of claim 49, wherein a magnetic field generator having a strength of 2 kilohenries may alternatively be used; a winding wire is wound around the needle; Instead of a DC power source attached to the needle, a DC power source is attached to the winding; Obviously longer needles are needed; Clearly, the polarity of the DC supply in the windings is such that it attracts negatively charged pathogens. For the procedure of claim 1, the tip of the biopsy amount of skin tissue in the patient's bloodstream is not introduced. 56. The method of claim 55, wherein said killing of pathogens and their genomes can be achieved using an oven that creates a fire fueled by any hydrocarbon fuel. 56. The vaccine can be achieved according to claim 55, wherein ultraviolet light is used to kill pathogens and their genomes. 56. The vaccine can be achieved according to claim 55, wherein X-rays are used to kill the pathogen and its genome. 56. The vaccine can be achieved according to claim 55, wherein gamma radiation is used to kill pathogens and their genomes. 56. The vaccine can be achieved according to claim 55, wherein infrared light is used to kill pathogens and their genomes. 56. The vaccine can be achieved according to claim 55, wherein any abrasive or harsh chemical is used to kill pathogens and their genomes. 56. The vaccine of claim 55, wherein any currently available class of bleaching agent group is used to kill the pathogen and its genome. 56. The vaccine can be achieved according to claim 55, wherein any pasteurizer with or without a vibrator machine is used to kill the pathogen and its genome. 56. The vaccine can be achieved according to claim 55, wherein an autoclave set at 500 to 1000°F for at least 20 minutes is used to kill the pathogen and its genome. 56. The vaccine can be achieved according to claim 55, wherein any enriched antibody material is used for killing pathogens and their genomes. 56. A vaccine can be achieved according to claim 55 wherein any magnetic field device comprising an electromagnetic element with a 100 Watt power source is used to kill pathogens and their genomes. 56. A vaccine according to claim 55, wherein any one or all combinations of claims 55 to 66 are used to kill a pathogen and its genome. Regarding the procedure of claim 1, the dead genome in the patient's bloodstream is not introduced. 69. The method of claim 68, wherein said killing of pathogens and their genomes can be achieved using an oven that creates a fire fueled by any hydrocarbon fuel. 69. The vaccine can be achieved according to claim 68, wherein ultraviolet light is used to kill pathogens and their genomes. 69. The vaccine can be achieved according to claim 68, wherein X-rays are used to kill the pathogen and its genome. 69. The vaccine can be achieved according to claim 68, wherein gamma radiation is used to kill the pathogen and its genome. 69. A vaccine can be achieved according to claim 68 wherein infrared light is used to kill pathogens and their genomes. 69. The vaccine can be achieved according to claim 68, wherein any abrasive or harsh chemical is used to kill pathogens and their genomes. 69. The vaccine of claim 68, wherein any currently available class of bleaching agent group is used to kill the pathogen and its genome. 69. The vaccine of claim 68 can be achieved wherein any pasteurizer with or without a vibrator machine is used to kill the pathogen and its genome. 69. The vaccine can be achieved according to claim 68, wherein an autoclave set at 500 to 1000°F for at least 20 minutes is used to kill the pathogen and its genome. 69. The vaccine of claim 68 can be achieved wherein any enriched antibody material is used for killing pathogens and their genomes. 69. A vaccine can be achieved according to claim 68 wherein any magnetic field device comprising an electromagnetic element with a 100 watt power source is used to kill pathogens and their genomes. 69. The vaccine of claim 68, wherein any one or all combinations of claims 55 to 66 are used to kill a pathogen and its genome. Regarding the procedure of claim 1, the dead genome or the skin tissue according to claim 1 is not introduced into the patient's bloodstream. 82. The method of claim 81, wherein said killing of pathogens and their genomes can be achieved using an oven that creates a fire fueled by any hydrocarbon fuel. 82. The vaccine can be achieved according to claim 81, wherein ultraviolet light is used to kill the pathogen and its genome. 82. The vaccine can be achieved according to claim 81, wherein X-rays are used to kill the pathogen and its genome. 82. The vaccine can be achieved according to claim 81, wherein gamma radiation is used to kill the pathogen and its genome. 82. A vaccine can be achieved according to claim 81 wherein infrared light is used to kill pathogens and their genomes. 82. A vaccine can be achieved according to claim 81 wherein any abrasive or harsh chemical is used to kill pathogens and their genomes. 82. The vaccine of claim 81, wherein any currently available class of bleaching agent group is used to kill the pathogen and its genome. 82. The vaccine of claim 81, wherein any pasteurizer with or without a vibrator machine is used to kill the pathogen and its genome. 82. The vaccine of claim 81, wherein an autoclave set at 500 to 1000°F for at least 20 minutes is used to kill the pathogen and its genome. 82. The vaccine of claim 81, wherein any enriched antibody material is used for killing pathogens and their genomes. 82. A vaccine can be achieved according to claim 81 wherein any magnetic field device comprising an electromagnetic element with a 100 Watt power source is used to kill pathogens and their genomes. 82. The vaccine of claim 81, wherein any one or all combinations of claims 81 to 92 are used to kill a pathogen and its genome. The procedure according to claim 14, wherein the tip of the biopsy amount is not introduced in the case of skin tissue in the patient's bloodstream. 95. The method of claim 94, wherein said treatment of pathogens and their genomes can be accomplished using an oven that creates a fire fueled by any hydrocarbon fuel. 95. The serum of claim 94, wherein ultraviolet light is used to treat the pathogen and its genome. 95. The serum of claim 94, wherein X-rays are used to treat the pathogen and its genome. 95. The serum of claim 94, wherein gamma radiation is used to treat the pathogen and its genome. 95. The serum of claim 94, wherein infrared light is used for treatment of the pathogen and its genome. 95. The serum of claim 94, wherein any abrasive or harsh chemical is used in the treatment of pathogens and their genomes. 95. The serum of claim 94, wherein any currently available class of bleaching agent group is used for treatment of the pathogen and its genome. 95. The serum of claim 94 can be achieved wherein any pasteurizer with or without a vibrator machine is used to kill the pathogen and its genome. 95. The serum of claim 94, wherein an autoclave set between 500-1000°F is used for treatment of the pathogen and its genome. 95. The serum of claim 94, wherein any enriched antibody material is used for the treatment of pathogens and their genomes. 95. The serum of claim 94, wherein any magnetic field generator device comprising an electromagnetic element with a 100 watt power supply is used to treat pathogens and their genomes. 95. The method of claim 94, wherein any one or all combinations of claims 94 to 105 can be achieved in serum used to treat pathogens and their genomes. For the procedure of claim 14 , the dead genome is not introduced into the patient's blood stream. 108. The method of claim 107, wherein said treatment of pathogens, and their genomes, in which a fire-producing oven fueled by any hydrocarbon fuel can be achieved. 108. The serum of claim 107, wherein ultraviolet light is used to treat the pathogen and its genome. 108. The serum of claim 107, wherein X-rays are used to treat the pathogen and its genome. 108. The serum of claim 107, wherein gamma ray is used to treat pathogens and their genomes. 108. The serum of claim 107, wherein infrared light is used to treat the pathogen and its genome. 108. The serum of claim 107, wherein any abrasive or harsh chemical is used to treat pathogens and their genomes. 108. The serum of claim 107, wherein any currently available class of bleaching agent group is used for the treatment of the pathogen and its genome. 108. The serum of claim 107 can be achieved wherein any pasteurizer with or without a vibrator machine is used to kill pathogens and their genomes. 108. The serum of claim 107, wherein an autoclave set at 500-1000°F is used for treatment of pathogens and their genomes. 108. The serum of claim 107, wherein any enriched antibody material is used for the treatment of pathogens and their genomes. 108. The serum of claim 107, wherein any magnetic field generator device comprising an electromagnetic element with a 100 watt power supply is used to treat pathogens and their genomes. 108. The method of claim 107, wherein any one or all combinations of claims 107 to 118 can be achieved in serum used to treat pathogens and their genomes. 15. The method according to claim 14, wherein the tip of the biopsy amount is not introduced in the case of a dead genome in skin tissue or in the patient's bloodstream. 121. The method of claim 120, wherein said treatment of pathogens and their genomes using a fire producing oven fueled by any hydrocarbon fuel can be accomplished. 121. The serum of claim 120, wherein ultraviolet light is used to treat the pathogen and its genome. 121. The serum of claim 120, wherein X-rays are used to treat the pathogen and its genome. 121. The serum of claim 120, wherein gamma ray is used to treat pathogens and their genomes. 121. The serum of claim 120, wherein infrared light is used to treat the pathogen and its genome. 121. The serum of claim 120, wherein any abrasive or harsh chemical is used to treat pathogens and their genomes. 121. The serum of claim 120, wherein any currently available class of bleaching agent group is used for treatment of the pathogen and its genome. 121. The serum of claim 120, wherein any pasteurizer with or without a vibrator machine is used to kill pathogens and their genomes. 121. The method of claim 120, wherein said serum 500-1000 degrees Fahrenheit, which can be achieved with an autoclave set between, is used for treatment of the pathogen and its genome. 121. The serum of claim 120, wherein any enriched antibody material is used for treatment of pathogens and their genomes. 121. The serum of claim 120, wherein any magnetic field generator device comprising an electromagnetic element with a 100 watt power supply is used to treat pathogens and their genomes. 121. The method of claim 120, wherein any one or all combinations of claims 120 to 131 can be achieved in serum used to treat pathogens and their genomes.

Images